Enhanced glucose oxidation in exercise-induced myocardial ischemia

Area of Science:

• Cardiology
• Metabolic Interventions
• Myocardial Ischemia Research

Background:

• Dichloroacetate (DCA) shows promise in animal models for aiding recovery from myocardial ischemia by boosting glucose oxidation.
• DCA is a pyruvate dehydrogenase agonist, a key enzyme in regulating glucose metabolism during ischemia.

Purpose of the Study:

• To assess the acute effectiveness of DCA as a metabolic anti-ischemic therapy in patients diagnosed with coronary artery disease (CAD).
• To evaluate DCA's impact on exercise-induced myocardial ischemia within a clinical trial setting.

Main Methods:

• A double-blind, randomized, crossover trial compared a single intravenous dose of DCA (50 mg/kg) against a placebo.
• The study involved 7 patients with single-vessel CAD and 34 with multiple-vessel CAD during dynamic exercise testing.
• Clinical and electrocardiographic variables were monitored, alongside Body Surface Potential Maps (BSPM) for detailed ST-segment analysis.

Main Results:

• No significant differences were observed in exercise duration, chest pain incidence, or ST depression between DCA and placebo groups.
• Heart rate was slightly higher with DCA at rest and during recovery, but blood pressure remained unchanged.
• BSPM analysis revealed no significant differences in the rate or extent of ST integral recovery post-exercise.

Conclusions:

• Acute administration of DCA did not clinically or electrocardiographically moderate exercise-induced myocardial ischemia in humans.
• Further research is needed to determine if DCA or similar agents are beneficial in other ischemic conditions like acute myocardial infarction or post-angioplasty.